ACCREDITATION COUNCIL FOR PHARMACY EDUCATION (EIN 362123871) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1970

Legal Domicile

Principal Officer

JANET P ENGLE

Phone

3126643575

Tax Period

2025-01-01 to 2025-12-31

ACCREDITATION COUNCIL FOR PHARMACY EDUCATION, founded in 1970, is a community nonprofit that reported $7.3M in total revenue in fiscal year 2025. The organization ran a surplus of $1.6M, a strong 22% operating margin.

Mission

ACCREDITATION OF PROFESSIONAL DEGREE PROGRAMS OF SCHOOLS OF PHARMACY AND ACCREDITATION OF PROVIDERS OF CONTINUING PHARMACEUTICAL EDUCATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $259,200

Program Service Revenue $6,443,378

Investment Income $548,629

Other Revenue $0

TOTAL REVENUE $7,251,207

Expense Breakdown

Grants Paid $0

Salaries & Benefits $3,184,785

Fundraising Expenses $0

Program Expenses $5,128,026

Other Expenses $2,479,824

TOTAL EXPENSES $5,664,609

Year-over-Year Comparison

	2025	2024	Change
Revenue	$7,251,207	$6,796,822	+0.1%
Expenses	$5,664,609	$5,730,378	0.0%
Net Income	$1,586,598	$1,066,444	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

200

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$459,504

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CINDY D STOWE	DIRECTOR	1.00	Director	$0	$0	$0
KIMBERLY CROLEY	PRESIDENT	1.00	Officer Director	$0	$0	$0
LUGINA MENDEZ-HARPER	DIRECTOR (LEFT 06/30/25)	1.00	Director	$0	$0	$0
AMY SEYBERT	DIRECTOR	1.00	Director	$0	$0	$0
DIANE B GINSBURG	SECRETARY-TREASURER	1.00	Officer Director	$0	$0	$0
JOHN CLAY KIRTLEY	DIRECTOR	1.00	Director	$0	$0	$0
KATHY M CAMPBELL	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL MONE	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
SHARON L YOUMANS	DIRECTOR	1.00	Director	$0	$0	$0
SUSAN E BUECHELE	DIRECTOR	1.00	Director	$0	$0	$0
MALCOLM J BROUSSARD	DIRECTOR (START 07/01/25)	1.00	Director	$0	$0	$0
JANET P ENGLE	EXECUTIVE DIRECTOR	40.00	Officer	$385,062	$74,442	$459,504
J GREGORY BOYER	ASSOCIATE EXECUTIVE DIRECTOR	40.00	Highest	$298,236	$42,825	$341,061
DIMITRA TRAVLOS	ASSISTANT EXECUTIVE DIRECTOR	40.00	Highest	$254,358	$72,892	$327,250
DAWN ZAREMBSKI	ASSOCIATE DIRECTOR, ACCREDITATION	40.00	Highest	$248,458	$30,293	$278,751
MARY KIERSMA	ASSOCIATE DIRECTOR OF PROFESSIONAL DEGREE PROGRAM	40.00	Highest	$208,638	$40,559	$249,197
KIMBERLY CATLEDGE	ASSISTANT DIRECTOR, CONTINUING PHARMACY EDUCATION	40.00	Highest	$168,638	$32,759	$201,397

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$7,251,207	$5,664,609	$19,210,408	$1,586,598
2024	$6,796,822	$5,730,378	$17,963,808	$1,066,444
2023	$6,534,455	$5,548,918	$15,196,834	$985,537
2022	$5,620,625	$5,150,334	$13,906,624	$470,291
2022	$5,620,625	$5,150,334	$13,906,624	$470,291
2021	$6,165,358	$4,693,958	$12,749,108	$1,471,400
2020	$5,565,955	$5,006,643	$10,007,291	$559,312
2019	$5,356,283	$4,692,511	$8,195,411	$663,772
2018	$4,669,882	$4,151,539	$7,544,477	$518,343

ACCREDITATION COUNCIL FOR PHARMACY EDUCATION